IV ketamine for hard-to-treat epilepsy in adults
Treatments studied
Part of Brain & nervous system clinical trials.
This Phase 2 study tests whether a low dose of IV ketamine can reduce seizures in adults with drug-resistant epilepsy. It may help people whose seizures continue despite trying at least two appropriate seizure medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult, age 18 or older
- You’ve tried at least two appropriate seizure medicines and still have seizures
- Your EEG test shows epilepsy that can be focal or generalized
- In the past month, you must have more than 4 specific seizure types
- Your seizure medicines (at least 1) must stay the same for about 12 weeks before starting
- You must be able to safely participate (not pregnant, not breast feeding, not with certain heart/brain conditions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if ketamine can help stop seizures that haven't responded to standard medicines. It is for adults whose seizures continue after two or more emergency treatments.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This trial is for people with severe major depression who may benefit from a single dose of ketamine. Researchers want to see if certain biomarkers in your blood or brain can predict how well ketamine works for you.
This early-stage study looks at how parts of brain cells respond to ketamine in people with depression who have not improved with usual antidepressants. It may help researchers find why ketamine works for some people and not others, and who might benefit.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.
Hear when a new Drug Resistant Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.